Documents | Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) | Guidance | NICE

Documents

A list of downloadable documents created during development.

Review proposal consultation

Review proposal consultation
Stakeholder matrix 07 January 2016 104.42 KB
Review proposal paper 07 January 2016 240.5 KB

Other information

TA23 Brain cancer - temozolomide: summary 04 November 2002 42.02 KB

Background information

TA23 Brain cancer - temozolomide: review decision - May 2011 information
Appendix A: decision paper presented to the Institute's Guidance Executive 11 May 2011 63.07 KB
Review decision information
TA23 Brain cancer - temozolomide: HTA report information
TA23 Brain cancer - temozolomide: HTA report 27 April 2001 311.54 KB
TA23 Brain cancer - temozolomide: review proposal - March 2011 information
Appendix A: provisional matrix of stakeholders 25 March 2011 18.01 KB
Appendix B: proposal paper presented to the Institute's Guidance Executive 25 March 2011 230.93 KB